{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:16:39Z","timestamp":1772165799067,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-05487-x","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:49:54Z","timestamp":1741067394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The importance of age as a prognostic predictor of childhood hepatoblastoma: an analysis of single-center childhood hepatoblastoma in China"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhen","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Man","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"5","key":"5487_CR1","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/pbc.24215","volume":"59","author":"LG Spector","year":"2012","unstructured":"Spector LG, Birch J. The epidemiology of hepatoblastoma. Pediatr Blood Cancer. 2012;59(5):776\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"5487_CR2","doi-asserted-by":"crossref","unstructured":"Tang M-J, Ma X-L, He X-L, Pan W-H, Zhang X-H, Jiang S-Y, et al. A multicenter prospective study on the management of hepatoblastoma in children: a report from the Chinese children\u2019s Cancer Group. World Journal of Pediatrics; 2023.","DOI":"10.1007\/s12519-023-00750-6"},{"issue":"22","key":"5487_CR3","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1200\/JCO.19.01067","volume":"38","author":"E Hiyama","year":"2020","unstructured":"Hiyama E, Hishiki T, Watanabe K, Ida K, Ueda Y, Kurihara S, et al. Outcome and late complications of Hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor 2 protocol. J Clin Oncol. 2020;38(22):2488\u201398.","journal-title":"J Clin Oncol"},{"issue":"5","key":"5487_CR4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(18)30895-7","volume":"20","author":"HM Katzenstein","year":"2019","unstructured":"Katzenstein HM, Langham MR, Malogolowkin MH, Krailo MD, Towbin AJ, McCarville MB, et al. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a children\u2019s Oncology Group, multicentre, phase 3 trial. Lancet Oncol. 2019;20(5):719\u201327.","journal-title":"Lancet Oncol"},{"issue":"1","key":"5487_CR5","first-page":"62","volume":"39","author":"J Feng","year":"2019","unstructured":"Feng J, Polychronidis G, Heger U, Frongia G, Mehrabi A, Hoffmann K. Incidence trends and survival prediction of hepatoblastoma in children: a population-based study. Cancer Commun (Lond). 2019;39(1):62.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"5487_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2016.02.051","volume":"375","author":"XJ Yuan","year":"2016","unstructured":"Yuan XJ, Wang HM, Jiang H, Tang MJ, Li ZL, Zou X, et al. Multidisciplinary effort in treating children with hepatoblastoma in China. Cancer Lett. 2016;375(1):39\u201346.","journal-title":"Cancer Lett"},{"issue":"10","key":"5487_CR7","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00383-013-3399-0","volume":"29","author":"E Hiyama","year":"2013","unstructured":"Hiyama E, Ueda Y, Onitake Y, Kurihara S, Watanabe K, Hishiki T, et al. A cisplatin plus pirarubicin-based JPLT2 chemotherapy for hepatoblastoma: experience and future of the Japanese Study Group for Pediatric Liver Tumor (JPLT). Pediatr Surg Int. 2013;29(10):1071\u20135.","journal-title":"Pediatr Surg Int"},{"issue":"1","key":"5487_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","volume":"18","author":"RL Meyers","year":"2017","unstructured":"Meyers RL, Maibach R, Hiyama E, H\u00e4berle B, Krailo M, Rangaswami A, et al. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the children\u2019s hepatic tumors international collaboration. Lancet Oncol. 2017;18(1):122\u201331.","journal-title":"Lancet Oncol"},{"issue":"1","key":"5487_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4143\/crt.2021.265","volume":"54","author":"PH Kim","year":"2022","unstructured":"Kim PH, Shin HJ, Yoon HM, Choi YH, Namgoong JM, Kim DY, et al. Children\u2019s hepatic tumors international collaboration-hepatoblastoma stratification (CHIC-HS) system for Pediatric patients with Hepatoblastoma: a Retrospective, Hospital-based Cohort Study in South Korea. Cancer Res Treat. 2022;54(1):253\u20138.","journal-title":"Cancer Res Treat"},{"issue":"12","key":"5487_CR10","doi-asserted-by":"publisher","first-page":"e29932","DOI":"10.1002\/pbc.29932","volume":"69","author":"M Ke","year":"2022","unstructured":"Ke M, Zhou Y, Chang-Zhen Y, Li L, Diao M. A nomogram model to predict prognosis of patients with hepatoblastoma. Pediatr Blood Cancer. 2022;69(12):e29932.","journal-title":"Pediatr Blood Cancer"},{"key":"5487_CR11","doi-asserted-by":"crossref","unstructured":"Huang J, Hu Y, Jiang H, Xu Y, Lu S, Sun F et al. CHIC Risk Stratification System for Predicting the Survival of Children with Hepatoblastoma: Data from Children with Hepatoblastoma in China. Front Oncol. 2020;10.","DOI":"10.3389\/fonc.2020.552079"},{"issue":"8","key":"5487_CR12","doi-asserted-by":"publisher","first-page":"e28350","DOI":"10.1002\/pbc.28350","volume":"67","author":"B Haeberle","year":"2020","unstructured":"Haeberle B, Rangaswami A, Krailo M, Czauderna P, Hiyama E, Maibach R, et al. The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: analysis from the children\u2019s hepatic tumors international collaboration (CHIC) database. Pediatr Blood Cancer. 2020;67(8):e28350.","journal-title":"Pediatr Blood Cancer"},{"issue":"23","key":"5487_CR13","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1200\/JCO.19.03166","volume":"38","author":"JA Beyea","year":"2020","unstructured":"Beyea JA, Lau C, Cooke B, Hall S, Nathan PC, Gupta S. Long-term incidence and predictors of significant hearing loss requiring hearing Assistive devices among Childhood Cancer survivors: a Population-based study. J Clin Oncol. 2020;38(23):2639\u201346.","journal-title":"J Clin Oncol"},{"issue":"1","key":"5487_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00383-010-2708-0","volume":"27","author":"T Hishiki","year":"2011","unstructured":"Hishiki T, Matsunaga T, Sasaki F, Yano M, Ida K, Horie H, et al. Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT. Pediatr Surg Int. 2011;27(1):1\u20138.","journal-title":"Pediatr Surg Int"},{"issue":"10","key":"5487_CR15","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.ejca.2011.12.011","volume":"48","author":"R Maibach","year":"2012","unstructured":"Maibach R, Roebuck D, Brugieres L, Capra M, Brock P, Dall\u2019Igna P, et al. Prognostic stratification for children with hepatoblastoma: the SIOPEL experience. Eur J Cancer. 2012;48(10):1543\u20139.","journal-title":"Eur J Cancer"},{"issue":"10","key":"5487_CR16","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/hpb.12112","volume":"15","author":"BJ Allan","year":"2013","unstructured":"Allan BJ, Parikh PP, Diaz S, Perez EA, Neville HL, Sola JE. Predictors of survival and incidence of hepatoblastoma in the paediatric population. HPB (Oxford). 2013;15(10):741\u20136.","journal-title":"HPB (Oxford)"},{"issue":"11","key":"5487_CR17","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/pbc.24655","volume":"60","author":"AD Trobaugh-Lotrario","year":"2013","unstructured":"Trobaugh-Lotrario AD, Chaiyachati BH, Meyers RL, H\u00e4berle B, Tomlinson GE, Katzenstein HM, et al. Outcomes for patients with congenital hepatoblastoma. Pediatr Blood Cancer. 2013;60(11):1817\u201325.","journal-title":"Pediatr Blood Cancer"},{"issue":"2 Pt 2","key":"5487_CR18","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/AOG.0b013e31825f377f","volume":"120","author":"ML Birsner","year":"2012","unstructured":"Birsner ML, Hoover-Fong J, Bytyci Telegrafi A, Hueppchen NA. Perinatal detection of familial adenomatous polyposis. Obstet Gynecol. 2012;120(2 Pt 2):500\u20133.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"5487_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000327580","volume":"30","author":"HA Al-Hussein","year":"2011","unstructured":"Al-Hussein HA, Graham EM, Tekes A, Huisman TA. Pre- and postnatal imaging of a congenital hepatoblastoma. Fetal Diagn Ther. 2011;30(2):157\u20139.","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"5487_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12253-008-9001-8","volume":"14","author":"H Ergin","year":"2008","unstructured":"Ergin H, Yildirim B, Dagdeviren E, Yagci B, Ozen F, Sen N, et al. A prenatally detected case of congenital hepatoblastoma. Pathol Oncol Res. 2008;14(1):97\u2013100.","journal-title":"Pathol Oncol Res"},{"issue":"24","key":"5487_CR21","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1002\/ajmg.a.32030","volume":"143a","author":"AC Smith","year":"2007","unstructured":"Smith AC, Shuman C, Chitayat D, Steele L, Ray PN, Bourgeois J, et al. Severe presentation of Beckwith-Wiedemann syndrome associated with high levels of constitutional paternal uniparental disomy for chromosome 11p15. Am J Med Genet A. 2007;143a(24):3010\u20135.","journal-title":"Am J Med Genet A"},{"issue":"6","key":"5487_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00247-007-0460-y","volume":"37","author":"M Lu","year":"2007","unstructured":"Lu M, Greer ML. Hypervascular multifocal hepatoblastoma: dynamic gadolinium-enhanced MRI findings indistinguishable from infantile hemangioendothelioma. Pediatr Radiol. 2007;37(6):587\u201391.","journal-title":"Pediatr Radiol"},{"issue":"1","key":"5487_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1046\/j.1469-0705.2000.00168.x","volume":"16","author":"JC Shih","year":"2000","unstructured":"Shih JC, Tsao PN, Huang SF, Yen BL, Lin JH, Lee CN, et al. Antenatal diagnosis of congenital hepatoblastoma in utero. Ultrasound Obstet Gynecol. 2000;16(1):94\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"5487_CR24","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/(SICI)1096-911X(199906)32:6<466::AID-MPO20>3.0.CO;2-1","volume":"32","author":"RA Ammann","year":"1999","unstructured":"Ammann RA, Plaschkes J, Leibundgut K. Congenital hepatoblastoma: a distinct entity? Med Pediatr Oncol. 1999;32(6):466\u20138.","journal-title":"Med Pediatr Oncol"},{"issue":"11","key":"5487_CR25","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/S0959-8049(00)00074-5","volume":"36","author":"J Brown","year":"2000","unstructured":"Brown J, Perilongo G, Shafford E, Keeling J, Pritchard J, Brock P, et al. Pretreatment prognostic factors for children with hepatoblastoma\u2013 results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer. 2000;36(11):1418\u201325.","journal-title":"Eur J Cancer"},{"key":"5487_CR26","doi-asserted-by":"crossref","unstructured":"Dall\u2019Igna P, Brugieres L, Christin AS, Maibach R, Casanova M, Alaggio R et al. Hepatoblastoma in children aged less than six months at diagnosis: a report from the SIOPEL group. Pediatr Blood Cancer. 2018;65(1).","DOI":"10.1002\/pbc.26791"},{"issue":"1","key":"5487_CR27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/s12887-019-1870-3","volume":"19","author":"W Yang","year":"2019","unstructured":"Yang W, Chen Y, Huang Y, Wang H. Analysis of factors related to recurrence of paediatric hepatoblastoma - a single centre retrospective study. BMC Pediatr. 2019;19(1):485.","journal-title":"BMC Pediatr"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05487-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-05487-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05487-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:50:00Z","timestamp":1741067400000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-05487-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5487"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-05487-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5240184\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study follows the Declaration of Helsinki. This single-center retrospective study was approved by the First Affiliated Hospital of Sun Yat-sen University (No. 2024[242]). This study was a retrospective study, and the Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University applied for exemption of informed consent and was approved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}